End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8,900 KRW | +1.60% |
|
+0.68% | -6.12% |
Business Summary
Sales per Business
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Anti-cancer Drugs
100.0
%
| 0 | nan % | 162 | 100.0 % | - |
Sales per region
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Singapore
100.0
%
| 0 | nan % | 162 | 100.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
So-Yeon Park
CEO | Chief Executive Officer | 61 | - |
Lai Wat Tay
DFI | Director of Finance/CFO | 68 | - |
Jin Woo Kim
COO | Chief Operating Officer | 60 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Lai Wat Tay
DFI | Director of Finance/CFO | 68 | - |
So-Yeon Park
CEO | Chief Executive Officer | 61 | - |
Eui-Kyung Lee
BRD | Director/Board Member | 65 | - |
Jin Woo Kim
COO | Chief Operating Officer | 60 | - |
Seung Joo Oh
BRD | Director/Board Member | 48 | - |
Kue Ho Bang
BRD | Director/Board Member | 61 | 14/06/23 |
Kok Fatt Lee
BRD | Director/Board Member | 51 | - |
Kyung Hee Jeon
BRD | Director/Board Member | 56 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 12,019,231 | 0 | 0 | - |
Stock B | 1 | 60,096,155 | 0 | 0 |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
PRESTIGE BIOLOGICS CO., LTD. 24.73% | 15,206,560 | 24.73% | 48,819,596 $ |
Company contact information
Prestige BioPharma Ltd.
04-24/28 Nucleos South Building 21 Biopolis Road
138567, Singapore
+
http://www.prestigebiopharma.com![address Prestige BioPharma Limited(A950210)](https://cdn.zonebourse.com/static/address/124598756.png)
Sector
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-6.12% | 75.99M | |
+2.88% | 93.97B | |
+6.58% | 41.61B | |
-13.20% | 33.32B | |
+77.12% | 28.8B | |
-16.02% | 15.61B | |
-8.17% | 13.27B | |
-12.49% | 11.46B | |
+162.44% | 10.06B | |
-54.92% | 9.09B |
- Stock Market
- Equities
- A950210 Stock
- Company Prestige BioPharma Limited